Citation Tools
PDFSmall intestinal disease
COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin
Download to a citation manager
Download the citation for this article by clicking on one of the following citation managers:
- Cite this article as:
- COX-2 inhibition with rofecoxib does not increase intestinal permeability in healthy subjects: a double blind crossover study comparing rofecoxib with placebo and indomethacin